Time Spent Walking or Exercising and Blood Levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3): A Large-Scale Cross-Sectional Study in the Japan Collaborative Cohort Study

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue SUPPL.1, 2009, Pages 23-28

  Wakai, Kenji ^a   Suzuki, Koji ^b   Ito, Yoshinori ^a   Watanabe, Yoshiyuki ^c,c   Inaba, Yutaka ^d   Tajima, Kazuo ^e   Nakachi, Kei ^f   Tamakoshi, Akiko ^g   Mori, Mitsuru ^h   Sakauchi, Fumio ^h   Motohashi, Yutaka ⁱ   Tsuji, Ichiro ^j   Nakamura, Yosikazu ^k   Iso, Hiroyasu ^l   Mikami, Haruo ^m   Kurosawa, Michiko ⁿ   Hoshiyama, Yoshiharu ^o   Tanabe, Naohito ^p   Tamakoshi, Koji ^q   Tokudome, Shinkan ^r   Hashimoto, Shuji ^s   Kikuchi, Shogo ^g   Wada, Yasuhiko ^t   Kawamura, Takashi ^u   Ozasa, Kotaro ^f   Miki, Tsuneharu ^v   Date, Chigusa ^f   Sakata, Kiyomi ^w   Kurozawa, Yoichi ^x   Yoshimura, Takesumi ^y   Fujino, Yoshihisa ^z   Shibata, Akira ^aa   Okamoto, Naoyuki ^ab   Shio, Hideo ^ac   more..

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d Faculty of Human Life Sciences   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^g AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k JICHI MEDICAL UNIVERSITY   (Japan)

^l OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^m CHIBA CANCER CENTER   (Japan)

ⁿ JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o UNIVERSITY OF HUMAN ARTS AND SCIENCES   (Japan)

^p NIIGATA UNIVERSITY   (Japan)

^q NAGOYA UNIVERSITY   (Japan)

^r NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^s FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^t KANSAI ROSAI HOSPITAL   (Japan)

^u KYOTO UNIVERSITY   (Japan)

^v NARA WOMEN'S UNIVERSITY   (Japan)

^w IWATE MEDICAL UNIVERSITY   (Japan)

^x TOTTORI UNIVERSITY   (Japan)

^y FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^z UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^aa KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ab KANAGAWA CANCER CENTER   (Japan)

^ac Moriyama Municipal Hospital   (Japan)

more..

Author keywords

Cancer risk; IGF I; IGFBP 3; Physical activity

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EXERCISE; FEMALE; HUMAN; JAPAN; LIFESTYLE; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR; WALKING;

ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; JAPAN; LIFE STYLE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; WALKING;

EID: 77957377276     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Allen NE, Appleby PN, Kaaks R, et al (2003). Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control, 14, 65-74.
2. Goodman-Gruen D, Barrett-Connor E (1997). Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol, 145, 970-6.
3. Grimberg A (2003). Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther, 2, 630-5.
4. Ito Y, Nakachi K, Imai K, et al (2005). Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor ®, soluble Fas, and superoxide dismutase activity for the JACC study. J Epidemiol, 15 Suppl 1, S67-73.
5. Iwai N, Hisamichi S, Hayakawa N, et al (2001). Validity and reliability of single-item questions about physical activity. J Epidemiol, 11, 211-8.
6. Kaaks R, Lukanova A (2001). Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc, 60, 91-106.
7. Ohno Y, Tamakoshi A, the JACC Study Group (2001). Japan Collaborative Cohort Study for Evaluation of Cancer Risk Sponsored by Monbusho (JACC study). J Epidemiol, 11, 144-50.
8. Renehan AG, Zwahlen M, Minder C, et al (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 363, 1346-53.
9. Roddam AW, Allen NE, Appleby P, et al (2008). Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med, 149, 461-71.
10. Tamakoshi A, Suzuki K, Ito Y, et al (2009). Selection of cases and controls for the nested case-control study within the JACC Study: the first-wave. Asian Pacific J Cancer Prev, 10 JACC Supp,1-6.
11. Tamakoshi A, Yoshimura T, Inaba Y, et al (2005). Profile of the JACC Study. J Epidemiol, 15 Suppl 1, S4-8.
12. Voskuil DW, Bueno de Mesquita HB, Kaaks R, et al (2001). Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control, 12, 951-8.
13. World Cancer Research Fund, American Institute for Cancer Research (2007). Physical activity. In 'Food, nutrition, physical activity, and the prevention of cancer: a global perspective'. American Institute for Cancer Research, Washington, DC pp 198-209.
14. Yu H, Rohan T (2000). Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst, 92, 1472-89.